Metropolitan Life Insurance CO Evolus, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$7.15 - $10.2 $3,296 - $4,702	461 Added 23.56%	2,418 $22,000
Q2 2023 Aug 10, 2023	BUY	$7.23 - $10.52 $5,458 - $7,942	755 Added 62.81%	1,957 $14,000
Q1 2023 May 15, 2023	SELL	$7.81 - $11.05 $8,559 - $12,110	-1,096 Reduced 47.69%	1,202 $10,000
Q4 2022 Jun 14, 2023	BUY	$6.52 - $8.95 $7,145 - $9,809	1,096 Added 91.18%	2,298 $17.3 Million
Q3 2022 Jun 14, 2023	BUY	$7.76 - $13.72 $8,504 - $15,037	1,096 Added 91.18%	2,298 $18.5 Million
Q2 2022 Jun 20, 2023	BUY	$10.22 - $13.94 $11,201 - $15,278	1,096 Added 91.18%	2,298 $26,000
Q1 2022 Jun 20, 2023	BUY	$5.22 - $11.78 $5,721 - $12,910	1,096 Added 91.18%	2,298 $25,000
Q1 2022 Mar 30, 2023	SELL	$5.22 - $11.78 $9,526 - $21,498	-1,825 Reduced 44.26%	2,298 $25,000
Q1 2022 May 12, 2022	BUY	$5.22 - $11.78 $11,995 - $27,070	2,298 New	2,298 $26,000
Q4 2021 Feb 15, 2022	SELL	$5.37 - $8.38 $22,140 - $34,550	-4,123 Closed	0 $0
Q3 2021 Jun 21, 2023	BUY	$7.36 - $13.67 $21,498 - $39,930	2,921 Added 243.01%	4,123 $31,000
Q3 2021 Mar 30, 2023	SELL	$7.36 - $13.67 $42,577 - $79,080	-5,785 Reduced 58.39%	4,123 $31,000
Q3 2021 Nov 15, 2021	SELL	$7.36 - $13.67 $42,577 - $79,080	-5,785 Reduced 58.39%	4,123 $31,000
Q2 2021 Jun 21, 2023	BUY	$8.42 - $13.96 $73,304 - $121,535	8,706 Added 724.29%	9,908 $125,000
Q2 2021 Mar 30, 2023	BUY	$8.42 - $13.96 $35,128 - $58,241	4,172 Added 72.73%	9,908 $125,000
Q2 2021 Aug 16, 2021	BUY	$8.42 - $13.96 $83,425 - $138,315	9,908 New	9,908 $125,000
Q4 2019 Feb 14, 2020	SELL	$11.58 - $17.37 $66,422 - $99,634	-5,736 Closed	0 $0
Q3 2019 Jul 12, 2023	BUY	$13.91 - $19.87 $63,067 - $90,090	4,534 Added 377.2%	5,736 $89,000
Q3 2019 Mar 30, 2023	BUY	$13.91 - $19.87 $28,404 - $40,574	2,042 Added 55.28%	5,736 $89,000
Q3 2019 Nov 14, 2019	BUY	$13.91 - $19.87 $79,787 - $113,974	5,736 New	5,736 $90,000
Q2 2019 Jul 12, 2023	BUY	$13.19 - $28.36 $32,869 - $70,673	2,492 Added 207.32%	3,694 $54 Million
Q2 2019 Aug 14, 2019	SELL	$13.19 - $28.36 $48,723 - $104,761	-3,694 Closed	0 $0
Q1 2019 Jul 13, 2023	BUY	$12.43 - $28.91 $30,975 - $72,043	2,492 Added 207.32%	3,694 $83,000
Q1 2019 Mar 30, 2023	BUY	$12.43 - $28.91 $17,352 - $40,358	1,396 Added 60.75%	3,694 $83,000
Q1 2019 May 16, 2019	BUY	$12.43 - $28.91 $2,610 - $6,071	210 Added 6.03%	3,694 $83,000
Q1 2019 May 15, 2019	BUY	$12.43 - $28.91 $43,306 - $100,722	3,484 New	3,484 $381,000

Others Institutions Holding EOLS

# of Institutions

168

Shares Held

47.8M

Call Options Held

130K

Put Options Held

51K

Perceptive Advisors LLC New York, NY

5.36M
Shares

$58.1 Million
2.27% of portfolio
Tang Capital Management LLC San Diego, CA

4.85M
Shares

$52.5 Million
6.69% of portfolio
Black Rock Inc. New York, NY

4.01M
Shares

$43.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.2M
Shares

$34.6 Million
0.0% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

2.82M
Shares

$30.6 Million
2.72% of portfolio

View Full List

About Evolus, Inc.

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $608M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

More about EOLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account